Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance, amount at Dec. 31, 2024 $ (20,054,339) $ 25,115 $ 19,948,363 $ (39,751,236) $ (276,581)
Beginning balance, shares at Dec. 31, 2024   25,115,299      
Net income (loss) (2,021,282)     (2,021,282)  
Foreign currency translation gain (loss) 151,790       151,790
Stock options exercised 127,000 $ 100 126,900    
Stock options exercised, shares   100,000      
Stock-based compensation 166,261 $ 38 166,223    
Stock-based compensation, shares   38,216      
Ending balance, amount at Mar. 31, 2025 (21,630,570) $ 25,253 20,241,486 (41,772,518) (124,791)
Ending balance, shares at Mar. 31, 2025   25,253,515      
Beginning balance, amount at Dec. 31, 2025 (17,474,275) $ 25,354 20,663,931 (38,267,617) 104,057
Beginning balance, shares at Dec. 31, 2025   25,354,623      
Net income (loss) 1,367,556     1,367,556  
Foreign currency translation gain (loss) (124,750)       (124,750)
Stock-based compensation 52,847 $ 0 52,847    
Stock-based compensation, shares   0      
Ending balance, amount at Mar. 31, 2026 $ (16,178,622) $ 25,354 $ 20,716,778 $ (36,900,061) $ (20,693)
Ending balance, shares at Mar. 31, 2026   25,354,623